Ameritas Investment Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
6,976
+904
| +15% | +$14.5K | ﹤0.01% | 1679 |
|
|
2025
Q1 | $104K | Hold |
6,072
| – | – | ﹤0.01% | 1676 |
|
|
2024
Q4 | $150K | Buy |
6,072
+487
| +9% | +$12.1K | ﹤0.01% | 1503 |
|
|
2024
Q3 | $159K | Hold |
5,585
| – | – | 0.01% | 1480 |
|
|
2024
Q2 | $147K | Hold |
5,585
| – | – | 0.01% | 1469 |
|
|
2024
Q1 | $180K | Hold |
5,585
| – | – | 0.01% | 1354 |
|
|
2023
Q4 | $235K | Buy |
5,585
+224
| +4% | +$9.44K | 0.01% | 1161 |
|
|
2023
Q3 | $206K | Buy |
5,361
+905
| +20% | +$34.7K | 0.01% | 1153 |
|
|
2023
Q2 | $84.5K | Buy |
4,456
+1,315
| +42% | +$24.9K | ﹤0.01% | 1711 |
|
|
2023
Q1 | $48.7K | Hold |
3,141
| – | – | ﹤0.01% | 1998 |
|
|
2022
Q4 | $55.9K | Hold |
3,141
| – | – | ﹤0.01% | 1987 |
|
|
2022
Q3 | $17K | Hold |
3,141
| – | – | ﹤0.01% | 2597 |
|
|
2022
Q2 | $12K | Hold |
3,141
| – | – | ﹤0.01% | 2782 |
|
|
2022
Q1 | $17K | Hold |
3,141
| – | – | ﹤0.01% | 2622 |
|
|
2021
Q4 | $27K | Hold |
3,141
| – | – | ﹤0.01% | 2497 |
|
|
2021
Q3 | $27K | Hold |
3,141
| – | – | ﹤0.01% | 2531 |
|
|
2021
Q2 | $33K | Hold |
3,141
| – | – | ﹤0.01% | 2448 |
|
|
2021
Q1 | $50K | Hold |
3,141
| – | – | ﹤0.01% | 2084 |
|
|
2020
Q4 | $145K | Buy |
3,141
+166
| +6% | +$7.66K | 0.01% | 1332 |
|
|
2020
Q3 | $105K | Buy |
2,975
+1,287
| +76% | +$45.4K | ﹤0.01% | 1393 |
|
|
2020
Q2 | $41K | Buy |
+1,688
| New | +$41K | ﹤0.01% | 1949 |
|